Pepdox
Studies
Peptides
Calculator
Home
/
Search
/
PMID 31525763
In poorly controlled type 2 diabetes, oral semaglutide was noninferior to liraglutide for reducing HbA1c.
Annals of internal medicine
2019
PMID: 31525763
View on PubMed
DOI: 10.7326/ACPJ201909170-029
Semaglutide
Authors
Lipscombe, Lorraine L
In poorly controlled type 2 diabetes, oral semaglutide was noninferior to liraglutide for reducing HbA1c. | Pepdox